Xoma Series B Preferred Stock (XOMAO)

• 1 day: 0%
• 5 days: -0.16%
• 1 month: -0.04%
• 3 months: -0.47%
• 6 months: -0.94%
• Year to date: 0.51%
• 1 year: -0.16%
• 5 years: 2.96%
• 10 years: 2.96%
• Sector: Healthcare
• Industry: Biotechnology

About: XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

Employees: 14